Evidence map›Paper›PMID 39960517›Full record

ReviewUrolithiasis2025

Recent developments in the study of cellular inflammation in the papillae of stone formers.

James C Williams, Tarek M El-Achkar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

James C WilliamsDepartment of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, 635 Barnhill Drive MedSci 5065A, Indianapolis, IN, 46202-5120, USA. jwillia3@iu.edu.
Tarek M El-AchkarDivision of Nephrology, Department of Medicine, Indiana University School of Medicine and The Indianapolis VA Medical Center, Indianapolis, IN, USA.

Funding

STONE FORMATION IN GENETIC HYPERCALCIURIAP01DK056788 · NIDDK · UNIVERSITY OF CHICAGO · PI WORCESTER, ELAINE M · 2000 to 2021
$22.5M
Essential characterization of the Randall's plaque-overgrowth interfaceR01DK124776 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI WILLIAMS, JAMES C · 2020 to 2022
$713k
NIDDK NIH HHS R01 DK124776NIH HHS P01 DK056788
6 · The paper itself

Abstract

Kidney stone disease has long been thought to involve tissue inflammation, but direct evidence linking inflammation as a causative factor in human stone formation remains limited. This review focuses on studies in human stone formers, highlighting variation in stone former phenotypes. Histological and molecular studies of kidney tissues reveal increased immune cell density and gene expression changes in stone formers, with notable differences between calcium oxalate and brushite stone pathologies. Phenotyping stone formers by tissue mineralization patterns-such as Randall's plaque or ductal plugging-shows significant heterogeneity in tissue damage, and thus presumably also inflammation. Systemic markers, such as elevated serum C-reactive protein, suggest a link between active stone disease and inflammation, although relationships vary with age, gender, and comorbidities. Such systemic markers have not been studied well in stone formers separated by phenotype. These insights underline the importance of stratifying patients by stone type and tissue pathology to identify inflammation pathways specific to each phenotype. Such an approach may pave the way for targeted anti-inflammatory therapies to reduce recurrence in this heterogeneous disease.

Indexed as

InflammationKidney CalculiKidney MedullaBiomarkersCalcium OxalateHumansPhenotypeBiomarkersCalcium OxalateCalcium oxalateKidney stonesNephrolithiasis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.